Skip to main content
. 2022 Nov 30;95(1):e28331. doi: 10.1002/jmv.28331

Table 3.

SR‐BI SNP genotypes and allele frequencies

HCV RNA

HCVIshak fibrosis

HCVIshak fibrosis

SRB1 genotype Positive Negative Severe Mild
n = 267 n = 107 n = 92 n = 160
rs4238001 GG 211 (79.0) 85 (79.4) 70 (76.1) 130 (81.3)
GA 52 (19.5) 20 (18.7) 22 (23.9) 27 (16.9)
AA 4 (1.5) 2 (1.9) 0 (0.0) 3 (1.9)
rs61932577 CC 217 (81.3) 80 (74.8) 74 (80.4) 129 (80.6)
CT 48 (18.0) 27 (25.2) 17 (18.5) 30 (18.8)
TT 2 (0.7) 0 (0.0) 1 (1.1) 1 (0.6)
rs5888 CC 70 (26.2) 37 (34.6) 19 (20.7) 48 (30.0)a , b
CT 137 (51.3) 53 (49.5) 45 (48.9) 84 (52.9)
TT 60 (22.5) 17 (15.9) 28 (30.4) 28 (17.5)
SRB1 alleles N  = 534 N  = 214 N  = 184 N  = 320
rs4238001 G 474 (88.8) 190 (88.8) 162 (88.0) 287 (89.7)
A 60 (11.2) 24 (11.2) 22 (12.0) 33 (10.3)
rs61932577 C 482 (90.3) 187 (87.4) 165 (89.7) 288 (90.0)
T 52 (9.7) 27 (12.6) 19 (10.3) 32 (10.0)
rs5888 C 277 (51.9) 127 (59.4) 83 (45.1) 180 (56.3)c
T 257 (48.1) 87 (40.6) 101 (54.9) 140 (43.7)

Abbreviations: n, number of subjects; N, number of alleles; percentages are given in brackets.

a

Genotype versus disease severity p = 0.039 (χ 2 test);

b

Homozygous genotype versus disease severity p = 0.014 (χ 2 test);

c

Allele frequency versus disease severity p = 0.016 (χ 2 test).